Exemestane-RAD001-Metformin

NCT01627067 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

23

Enrollment

OTHER

Sponsor class

Stopped Komen Foundation Funding Terminated

Conditions

Breast Cancer

Interventions

DRUG: Everolimus
DRUG: Exemestane
DRUG: Metformin

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]